[Quinolones]

Enferm Infecc Microbiol Clin. 2003 May;21(5):261-7; quiz 268, 272. doi: 10.1016/s0213-005x(03)72932-2.
[Article in Spanish]

Abstract

Quinolones act by inhibiting enzymes (topoisomerases), which are indispensable to DNA synthesis. Their bactericidal activity is concentration-dependent. Their spectrum has become broader, especially since the introduction of a fluorine atom at position 6 (fluoroquinolones). They are used as the treatment of choice or as alternative therapy in a wide variety of infections, both in the hospital and non-hospital setting. Depending on the compound, they are used in urinary tract infections, sexually transmitted diseases, chronic osteomyelitis, respiratory tract infections, and severe systemic infections, among others. The upsurge and extent of quinolone resistance has limited the use of these agents in some cases and in future may determine their use in others. There are strategies to minimize the spread of resistance. Quinolones are safe and well tolerated. The most frequent adverse effects are gastrointestinal and those affecting the central nervous system.

Publication types

  • English Abstract
  • Review

MeSH terms

  • 4-Quinolones
  • Anti-Infective Agents* / adverse effects
  • Anti-Infective Agents* / classification
  • Anti-Infective Agents* / pharmacology
  • Anti-Infective Agents* / therapeutic use
  • Bacterial Infections / drug therapy
  • Drug Resistance
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Structure-Activity Relationship
  • Topoisomerase Inhibitors

Substances

  • 4-Quinolones
  • Anti-Infective Agents
  • Enzyme Inhibitors
  • Topoisomerase Inhibitors